ASTEX PHARMACEUTICALS, INC Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities
ASTEX PHARMACEUTICALS, INC reported Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities of $136.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2013-03-31 was $136.00K.
- ASTEX PHARMACEUTICALS, INC dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2012-06-30 was $111.00K.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 3 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 6 month |
|---|---|---|
| 2013-03-31 | $136.00K 10-Q · filed 2013-05-10 | |
| 2012-06-30 | $111.00K 10-Q · filed 2013-08-09 | $25.00K 10-Q · filed 2013-08-09 |